Burning Rock Biotech Ltd(BNR)Stock Analysis

BNR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Burning Rock Biotech Ltd (BNR), a Healthcare sector company. BNR is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 16 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Burning Rock Biotech Ltd reports quarterly revenue of $77.2M, net income of $-7.9M, an operating margin of -10.2%. Top institutional holders of BNR by reported 13-F value include Kynam Capital Management,, CRCM, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. BNR trades on the Nasdaq exchange and files with the SEC under CIK 1792267. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BNR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Burning Rock Biotech Ltd directly from SEC EDGAR.